Scott A. Beers

764 total citations
17 papers, 656 citations indexed

About

Scott A. Beers is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Scott A. Beers has authored 17 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Scott A. Beers's work include Bone health and treatments (3 papers), Cancer therapeutics and mechanisms (3 papers) and Organophosphorus compounds synthesis (3 papers). Scott A. Beers is often cited by papers focused on Bone health and treatments (3 papers), Cancer therapeutics and mechanisms (3 papers) and Organophosphorus compounds synthesis (3 papers). Scott A. Beers collaborates with scholars based in United States, Netherlands and China. Scott A. Beers's co-authors include Elizabeth A. Malloy, A.W. Jongbloed, Charles F. Schwender, Michael P. Wachter, Deborah A. Loughney, Keith T. Demarest, Yasuhiro Imakura, Kuo-Hsiung Lee, Janet E. Davis and Druie Cavender and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry.

In The Last Decade

Scott A. Beers

17 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott A. Beers United States 13 349 281 93 87 70 17 656
Kuo‐Long Yu United States 16 311 0.9× 321 1.1× 51 0.5× 59 0.7× 16 0.2× 29 763
Jens Breinholt Denmark 17 350 1.0× 330 1.2× 50 0.5× 205 2.4× 23 0.3× 40 1.1k
Xiaoyi Zhu Australia 13 460 1.3× 121 0.4× 68 0.7× 319 3.7× 32 0.5× 25 861
Todd L. Graybill United States 16 414 1.2× 351 1.2× 125 1.3× 46 0.5× 10 0.1× 29 818
Ryszard Szyszka Poland 19 700 2.0× 110 0.4× 77 0.8× 73 0.8× 6 0.1× 47 891
Ian Parsons Australia 12 478 1.4× 136 0.5× 51 0.5× 177 2.0× 10 0.1× 29 790
Stanley J. Schmidt United States 12 323 0.9× 193 0.7× 62 0.7× 11 0.1× 11 0.2× 21 546
TOMIO TAKEUCHI Japan 16 411 1.2× 332 1.2× 79 0.8× 75 0.9× 6 0.1× 37 793
Vinh Tran United States 13 242 0.7× 345 1.2× 18 0.2× 109 1.3× 11 0.2× 20 757
Moritz Werder Switzerland 17 694 2.0× 311 1.1× 244 2.6× 21 0.2× 11 0.2× 22 1.2k

Countries citing papers authored by Scott A. Beers

Since Specialization
Citations

This map shows the geographic impact of Scott A. Beers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Beers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Beers more than expected).

Fields of papers citing papers by Scott A. Beers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott A. Beers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Beers. The network helps show where Scott A. Beers may publish in the future.

Co-authorship network of co-authors of Scott A. Beers

This figure shows the co-authorship network connecting the top 25 collaborators of Scott A. Beers. A scholar is included among the top collaborators of Scott A. Beers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott A. Beers. Scott A. Beers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wadsworth, Scott, Druie Cavender, Scott A. Beers, et al.. (1999). RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase. Journal of Pharmacology and Experimental Therapeutics. 291(2). 680–687. 133 indexed citations
2.
Beers, Scott A., Elizabeth A. Malloy, Wei Wu, et al.. (1997). N-(5-substituted) thiophene-2-alkylsulfonamides as potent inhibitors of 5-lipoxygenase. Bioorganic & Medicinal Chemistry. 5(4). 779–786. 29 indexed citations
3.
Beers, Scott A., Elizabeth A. Malloy, Wei Wu, et al.. (1997). Nitroarylhydroxymethylphosphonic acids as inhibitors of CD45. Bioorganic & Medicinal Chemistry. 5(12). 2203–2211. 19 indexed citations
4.
Hu, Honggang, et al.. (1997). Anti-AIDS agents. 291. Anti-HIV activity of modified podophyllotoxin derivatives. Bioorganic & Medicinal Chemistry Letters. 7(22). 2897–2902. 17 indexed citations
5.
Frechette, Roger, et al.. (1997). Novel hydroxyphosphonate inhibitors of CD-45 tyrosine phosphatase. Bioorganic & Medicinal Chemistry Letters. 7(17). 2169–2172. 42 indexed citations
6.
Beers, Scott A., et al.. (1996). Phosphatase inhibitors—III. Benzylaminophosphonic acids as potent inhibitors of human prostatic acid phosphatase. Bioorganic & Medicinal Chemistry. 4(10). 1693–1701. 81 indexed citations
7.
Schwender, Charles F., et al.. (1996). Benzylphosphonic acid inhibitors of human prostatic acid phosphatase. Bioorganic & Medicinal Chemistry Letters. 6(3). 311–314. 23 indexed citations
8.
Vince, Robert, Jay Brownell, & Scott A. Beers. (1995). 6-Deoxycarbovir: A Xanthine Oxidase Activated Prodrug of Carbovir. Nucleosides and Nucleotides. 14(1-2). 39–44. 6 indexed citations
9.
Schwender, Charles F., et al.. (1995). 1-Naphthylmethylphosphonic acid derivatives as osteoclastic acid phosphatase inhibitors. Bioorganic & Medicinal Chemistry Letters. 5(16). 1801–1806. 26 indexed citations
10.
Vince, Robert, et al.. (1995). 6-Substituted Derivatives of Carbovir: Anti-HIV Activity. Nucleosides and Nucleotides. 14(8). 1703–1708. 6 indexed citations
11.
Beers, Scott A. & A.W. Jongbloed. (1992). Effect of supplementaryAspergillus nigerphytase in diets for piglets on their performance and apparent digestibility of phosphorus. Animal Science. 55(3). 425–430. 50 indexed citations
12.
Zimmerman, Cheryl L., et al.. (1992). Pharmacokinetic evaluation of (-)-6-aminocarbovir as a prodrug for (-)-carbovir in rats.. Drug Metabolism and Disposition. 20(1). 47–51. 11 indexed citations
13.
14.
Jongbloed, A.W., et al.. (1990). A comparison of different techniques to assess the biological availability of feed phosphates in pig feeding.. Netherlands Journal of Agricultural Science. 38(3B). 555–566. 35 indexed citations
15.
Beers, Scott A., et al.. (1990). The digestibility of phosphorus in some feed phosphates.. 1 indexed citations
16.
Lee, Kuo-Hsiung, Yasuhiro Imakura, Mitsumasa Haruna, et al.. (1989). Antitumor Agents, 107. New Cytotoxic 4-Alkylamino Analogues of 4'-Demethyl-Epipodophyllotoxin as Inhibitors of Human DNA Topoisomerase II. Journal of Natural Products. 52(3). 606–613. 66 indexed citations
17.
Beers, Scott A., et al.. (1988). Antitumor Agents, 99. Synthetic Ring C Aromatized Podophyllotoxin Analogues as Potential Inhibitors of Human DNA Topoisomerase II. Journal of Natural Products. 51(5). 901–905. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026